Showing results (1861-1870 of 9,980) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|April 18, 2009
Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantationSunday Ocheni, Gabriela B Iwanski, Philippe Schafhausen, et al.Leukemia & Lymphoma|April 18, 2009
Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphomaAna I Saez, Mónica García-Cosío, Antonio J Sáez, et al.Leukemia & Lymphoma|April 18, 2009
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemiaDavide Rossi, Lisa Sala, Rosalba Minisini, et al.Leukemia & Lymphoma|April 18, 2009
Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell lineFang Gao, Hao Li, Ya-Dong Chen, et al.Leukemia & Lymphoma|March 31, 2009
Composite lymphoma with relapse of enteropathy-type T-cell lymphomaZunguo Du, Jieqing Chen, Xiaoyan Zhou, et al.Leukemia & Lymphoma|March 31, 2009
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphomaHyo Song Kim, Kyung Hee Kim, Kyoung Ha Kim, et al.Leukemia & Lymphoma|November 7, 2022
Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapyKathrin Tyryshkin, Alison Moore, David Good, et al.Leukemia & Lymphoma|September 16, 2022
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCLToshiki Terao, Takafumi Tsushima, Daisuke Ikeda, et al.Leukemia & Lymphoma|September 20, 2022
Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)Ana Villalba, Ana Pilar Gonzalez-Rodriguez, Javier Arzuaga-Mendez, et al.Leukemia & Lymphoma|October 25, 2022
Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic reviewMoazzam Shahzad, Sibgha Gull Chaudhary, Ezza Tariq, et al.Pageof 998